Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

New consensus statement recommends transition of care for adolescents with neurologic disorders

A new consensus statement provides recommendations for transitioning adolescents and young adults with neurologic disorders to adult care.

28 Jul 2016

Study reveals long-term safety of AAV2-neurturin gene therapy in patients with Parkinson's disease

New safety data from a study of patients with advanced Parkinson's disease five years after gene transfer-mediated delivery of the neuroprotective factor neurturin directly to patients' brains reveal no serious adverse events related to the treatment.

27 Jul 2016

Study sheds light on neuronal circuits during risky behavior

New research sheds light on what's going on inside our heads as we decide whether to take a risk or play it safe. Scientists at Washington University School of Medicine in St. Louis located a region of the brain involved in decisions made under conditions of uncertainty, and identified some of the cells involved in the decision-making process.

27 Jul 2016

New technology allows researchers to temporarily shut down brain area to better understand function

Capitalizing on experimental genetic techniques, researchers at the California National Primate Research Center, or CNPRC, at the University of California, Davis, have demonstrated that temporarily turning off an area of the brain changes patterns of activity across much of the remaining brain.

22 Jul 2016

Cinnamon treatment turns poor-learning mice into good ones, research shows

If Dr. Kalipada Pahan's research pans out, the standard advice for failing students might one day be: Study harder and eat your cinnamon!

22 Jul 2016

Scientists receive $2.4 million grant to advance stem cell therapy for Parkinson's disease

Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.

22 Jul 2016

Shared lifestyle and environment may contribute to risk of common diseases in families, study shows

Family history of disease may be as much the result of shared lifestyle and surroundings as inherited genes, research has shown.

21 Jul 2016

FDA approves scalpel-free brain surgery to treat essential tremor

The Food and Drug Administration has approved the first focused ultrasound device to treat essential tremor, the most common movement disorder, in patients who do not respond to medication.

21 Jul 2016

New virus-based method opens wide range of options to treat various diseases

The ability to switch disease-causing genes on and off remains a dream for many physicians, research scientists and patients.

20 Jul 2016

Researchers discover novel neuroprotection strategies to slow progression of Parkinson's disease

Using a robust model for Parkinson's disease, University of Alabama at Birmingham researchers and colleagues have discovered an interaction in neurons that contributes to Parkinson's disease, and they have shown that drugs now under development may block the process.

20 Jul 2016

New research shows how toxic Alzheimer's protein spreads through the brain

A toxic Alzheimer's protein can spread through the brain--jumping from one neuron to another--via the extracellular space that surrounds the brain's neurons, suggests new research from Columbia University Medical Center.

19 Jul 2016

Study finds no increased risk for parkinsonism linked to use of gadolinium in MRIs

A new study from Lawson Health Research Institute and the Institute for Clinical Evaluative Sciences has cast doubt on the clinical significance of brain deposits of gadolinium.

19 Jul 2016

Postmenopausal estrogen supplement may not affect memory of healthy women

Contrary to popular belief, taking estrogen after menopause may not affect the memory and thinking abilities of healthy women no matter when the treatment is started.

19 Jul 2016

Duke University study provides new mechanistic understanding of OCD

A single chemical receptor in the brain is responsible for a range of symptoms in mice that are reminiscent of obsessive-compulsive disorder (OCD), according to a Duke University study that appears online in the journal Biological Psychiatry.

17 Jul 2016

Findings offer renewed hope for speedy development curative medicines for people with toxoplasmosis

In the July 14 edition of Scientific Reports (Nature), 39 researchers from 14 leading institutions in the United States, United Kingdom and France suggest novel approaches that could hasten the development of better medications for people suffering from toxoplasmosis.

17 Jul 2016

Genes linked to Alzheimer's disease may show effects on the brain from childhood

A gene associated with Alzheimer's disease and recovery after brain injury may show its effects on the brain and thinking skills as early as childhood, according to a study published in the July 13, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.

14 Jul 2016

Scientists identify timing of major metabolic shift in developing neurons

Our brains can survive only for a few minutes without oxygen. Salk Institute researchers have now identified the timing of a dramatic metabolic shift in developing neurons, which makes them become dependent on oxygen as a source of energy.

13 Jul 2016

Selfish mutant mtDNA exploits cellular defenses to cause many diseases

Mitochondrial disorders are a chameleon-like set of diseases that take many different forms and vary widely from individual to individual.

12 Jul 2016

Neuroscientists identify two distinct populations of dopamine neurons involved in movement, reward

Two Northwestern University neuroscientists have identified the neurochemical signal likely missing in Parkinson's disease by being the first to discover two distinctly different kinds of neurons that deliver dopamine to an important brain region responsible for both movement and learning/reward behavior.

12 Jul 2016

Leukemia drug increases brain dopamine, lowers toxic proteins linked to Parkinson's or dementia

A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson's disease or dementia with Lewy bodies.

12 Jul 2016

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

New consensus statement recommends transition of care for adolescents with neurologic disorders

Study reveals long-term safety of AAV2-neurturin gene therapy in patients with Parkinson's disease

Study sheds light on neuronal circuits during risky behavior

New technology allows researchers to temporarily shut down brain area to better understand function

Cinnamon treatment turns poor-learning mice into good ones, research shows

Scientists receive $2.4 million grant to advance stem cell therapy for Parkinson's disease

Shared lifestyle and environment may contribute to risk of common diseases in families, study shows

FDA approves scalpel-free brain surgery to treat essential tremor

New virus-based method opens wide range of options to treat various diseases

Researchers discover novel neuroprotection strategies to slow progression of Parkinson's disease

New research shows how toxic Alzheimer's protein spreads through the brain

Study finds no increased risk for parkinsonism linked to use of gadolinium in MRIs

Postmenopausal estrogen supplement may not affect memory of healthy women

Duke University study provides new mechanistic understanding of OCD

Findings offer renewed hope for speedy development curative medicines for people with toxoplasmosis

Genes linked to Alzheimer's disease may show effects on the brain from childhood

Scientists identify timing of major metabolic shift in developing neurons

Selfish mutant mtDNA exploits cellular defenses to cause many diseases

Neuroscientists identify two distinct populations of dopamine neurons involved in movement, reward

Leukemia drug increases brain dopamine, lowers toxic proteins linked to Parkinson's or dementia

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in